Page last updated: 2024-10-28

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Respiratory Distress Syndrome

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Respiratory Distress Syndrome in 2 studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanigaki, T1
Suzuki, Y1
Heimer, D1
Wang, W1
Sussman, HH1
Ross, WG1
Murphy, GA1
Ikeda, H1
Raffin, TA1
Struhar, D1
Harbeck, RJ1

Other Studies

2 other studies available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Respiratory Distress Syndrome

ArticleYear
The protein kinase C inhibitor, H-7, induces acute lung injury in guinea pigs.
    Critical care medicine, 1994, Volume: 22, Issue:7

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Bronchoalveolar Lavage Fluid; Cell Membrane

1994
Inhibition of induced acute lung edema by a novel protein kinase C inhibitor.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 1987, Volume: 1, Issue:2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Albumins; Animals; Disease Models, Animal; Enzyme Act

1987